George Yancopoulos, EVP, CSO, & President Regn Res Labs at REGENERON PHARMACEUTICALS INC (REGN), sold 9,556 shares at $23.85 ($228K) on 2007-04-09, disclosed to the SEC on 2007-04-11.
Scheduled sale ($228k) by EVP, CSO, & President Regn Res Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.80 | 3,100 | $74K | 32.4% |
| 2 | $23.81 | 715 | $17K | 7.5% |
| 3 | $23.82 | 1,820 | $43K | 19.0% |
| 4 | $23.83 | 945 | $23K | 9.9% |
| 5 | $23.84 | 2,120 | $51K | 22.2% |
| 6 | $23.85 | 456 |
| $11K |
| 4.8% |
| 7 | $23.85 | 300 | $7K | 3.1% |
| 8 | $23.86 | 100 | $2K | 1.0% |
| Total | $23.82 avg | 9,556 | $228K | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |